Paratek Pharmaceuticals Is An Independent Biopharmaceutical Company Focused On Developing And Commercializing Innovative Therapies For Life Threatening Diseases And Public Health Threatsfounded In 1996 And Headquartered In King Of Prussiapennsylvaniaparatek Addresses Critical Issues Such As Antimicrobial Resistancewhich Poses Significant Challenges To Global Health The Company Has Developed Key Products Based On Tetracycline Chemistryincluding Nuzyraomadacycline A Broad Spectrum Antibiotic Approved For Treating Community Acquired Bacterial Pneumonia And Acute Bacterial Skin Infectionsparatek Also Has Rights To Seysarasarecycline An Fda Approved Treatment For Moderate To Severe Acne Vulgariswhich Is Marketed By Almirall In The U Sand Greater Chinaparatek Retains Development And Commercialization Rights For This Product Outside Those Regions Paratek Serves A Diverse Customer Baseincluding Civiliangovernmentand Military Sectorsaiming To Provide Effective Solutions For Healthcare Providers And Patients Facing Serious Infectionsthe Company Is Backed By Novo Holdings Asenhancing Its Capacity To Deliver Life Saving Therapies
No conferences found for this company.
| Company Name | Paratek Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
